A Vaccine for Breast Cancer?

The video discusses the development of a breast cancer vaccine targeting HER2-positive cancer cells. A phase one clinical trial with 66 patients showed promising immune responses with manageable side effects. The vaccine uses a plasmid-based approach to stimulate T cells against the HER2 protein. While the trial focused on safety and immune response, further trials are needed to assess its impact on cancer growth. Future phases will determine the vaccine's efficacy and potential FDA approval.

What new insight or understanding did you gain from this video?